Centralized intravenous additive services (CIVAS): The state of the art in 2010;UCRI, unité centralisée de reconstitution d'injectables le point en 2010

Annales Pharmaceutiques Francaises

Volumn 69, Issue 1, 2011, Pages 30-37

  Hecq, J D ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

CIVAS; Compounding; Errors; Intravenous infusion; Patient care; Patient safety

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CEFEPIME; CEFTAZIDIME; CEFUROXIME; CYTOTOXIC AGENT; DISINFECTANT AGENT; DRUG ADDITIVE; PARENTERAL SOLUTION; PIPERACILLIN PLUS TAZOBACTAM; POLYOLEFIN; VANCOMYCIN;

ARTICLE; BACILLUS; CANCER CHEMOTHERAPY; CENTRALIZATION; CENTRALIZED INTRAVENOUS ADDITIVE SERVICE; COMPUTER PROGRAM; DRUG CONTAMINATION; DRUG COST; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG QUALITY; DRUG STABILITY; EQUIPMENT; FEVER; HEALTH CARE MANAGEMENT; HOSPITAL PHARMACY; HUMAN; INFECTION; KLEBSIELLA PNEUMONIAE; LAMINAR AIRFLOW; MICROBIAL CONTAMINATION; NONHUMAN; PARENTERAL NUTRITION; PHARMACEUTICAL ENGINEERING; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; RISK MANAGEMENT; RISK REDUCTION; STANDARDIZATION;

ANTINEOPLASTIC AGENTS; DRUG COMPOUNDING; DRUG CONTAMINATION; DRUG STABILITY; FRANCE; HUMANS; MEDICATION ERRORS; NURSES; PARENTERAL NUTRITION; PHARMACY SERVICE, HOSPITAL;

EID: 79551579106     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2010.09.002     Document Type: Article

References (76)

1. Turco S.J. Parenteral admixtures and incompatibilities. Sterile dosage forms. Their preparation and clinical application 1994, Lippincott Williams & Wilkins, Baltimore, MD, 239. 4th ed.
2. Simmons B.P. CDC guidelines for the prevention and control of nosocomial infections, guideline for prevention of intravascular infections. Am J Infect Control 1983, 11:183-199.
3. Taxis K., Barber N. Ethnographic study of incidence and severity of intravenous drug errors. Br Med J 2003, 326:684-690.
4. Kwan J.W., Anderson R.W. Pharmacists's knowledge of infusion devices. Am J Hosp Pharm 1991, 48:S52-S53.
5. Rwabihama J.P., Aubourg R., Oliary J., et al. Usage et mésusage de la voie intraveineuse pour l'administration de médicaments en médecine interne. Presse Med 2006, 35:1453-1460.
6. Clarck C. Safety with injectable medicines. Clin Pharm Eur 2007, 7:13-16.
7. Allen L.V. Parenteral admixture incompatibilities: an introduction. Int J Pharm Compd 1997, 1:165-167.
8. Barnes A.R. Near-patient stabilities. J Clin Pharm Ther 1996, 21:49-55.
9. Connors K.A., Amidon G.L., Stella V.A. Principles of chemical stability of pharmaceuticals. Chemicals stability of pharmaceuticals 1986, John Wiley & Sons, New York. 2nd ed.
10. Delneuville I. Quelques aspects galéniques de la préparation injectable en milieu hospitalier. Journée de formation post-universitaire de l'Association francophone des pharmaciens hospitaliers de Belgique; 1994.
11. Gindre I. Création d'une base de données sur CD-Rom, conçue dans un langage international à base de pictogrammes, concernant la stabilité et la compatibilité des médicaments injectables. Mémoire du diplôme d'études spécialisées de pharmacie hospitalière et des collectivités 2000, Faculté de pharmacie, université Poincaré-Nancy I.
12. Hecq J.D., Evrard J.M., Matheise G. Stabilité de quelques médicaments utilisés en PCA. Douleur Analg 1993, 3:85-100.
13. Jaminet F. Inconvénients et incompatibilités des associations médicamenteuses dans les solutions pour perfusion. Pharmakon 1974, 18:7-31.
14. Lima H.A. Drug stability and compatibility. Specials considerations for home health care. Int J Pharm Compd 1997, 1:301-305.
15. Myhr K. Addition of drugs to infusion fluids. Pharmaceuticals considerations on preparation and use. Acta Anaesthesiol Scand 1985, 29:71-75.
16. Newton D.W. Physicochemical determinants of incompatibility and instability in injectable drug solutions and admixtures. Handbook on injectable drugs 1980, ASHP, Washington. 2nd ed.
17. Newton D.W. Physicochemical determinants of incompatibility and instability of drugs for injection and infusion. Handbook on injectable drugs 1983, ASHP, Bethesda, MD. 3rd ed.
18. Stella V.J. Fondamentals of drug stability and compatibility. Handbook on injectable drugs 1986, ASHP, Bethesda, MD. 4th ed.
19. Trissel L.A. Drug stability and compatibility issues in drug delivery. Handbook on injectable drugs 1992, ASHP, Bethesda, MD. 7th ed.
20. Dickerson R.N., Brown R.O., White K.G. Parenteral nutrition solutions. Clinical nutrition. Parenteral nutrition 1993, Editions Saunders Company, [edited by Rombeau JL and Caldwell MD]. 2nd ed.
21. Maki D.G., Mermel L.A. Infections due to infusion therapy. Hospital infections 1998, Raven Publishers, Lippincott, [edited by Bennett JV and Brachman PS]. 4th ed.
22. Gandy R., Beaumont I., Lee G., Cumming I. Risk management and the aseptic preparation of medicines. EHP 1998, 4:114-119.
23. O'Hare J.M., Shapiro M.W., Creeden F.V. Fatal reaction following intravenous 10% dextrose. Am J Surg 1953, 85:658-663.
24. Michaels I., Ruebner B. Growth of bacteria in infusion fluids. Lancet 1953, 261:772-774.
25. Wilmore D.W., Dudrick S.J. An in-line filter for intravenous solutions. Arch Surg 1961, 99:462-463.
26. Holmes C.J., Allwood M.C. The microbiological contamination of intravenous infusions during clinical use. J Appl Bacteriol 1979, 46:247-267.
27. Ernerot L., Thoren S., Sandell E. Studies on microbial contamination of infusion fluids arising from drug additives and administration. Acta Pharm Suec 1973, 10:141-146.
28. Woodside W., Woodside M.E., D'Arcy E.M. Intravenous fluids as vehicle of infection. Pharm J 1975, 215:606.
29. Deeb E.N., Natsios G.A. Contamination of intravenous fluids by bacteria and fungi during preparation and administration. Am J Hosp Pharm 1971, 28:764-767.
30. Letcher K.I., Thrupp L.D., Shapiro D.J. In use contamination of intravenous solutions in flexible plastic containers. Am J Hosp Pharm 1972, 29:673-676.
31. Dieu B. Étude de la contamination microbienne des mélanges médicamenteux extemporanés administrés par perfusion veineuse 1983, Faculté de médecine et de pharmacie de Rouen.
32. Mansfield A. An observational study in four hospitals. Current issues in intravenous preparation and administration in Europe. Baxter satellite symposium. EAHP Amsterdam; 2001.
33. Cousins D.H., Sabatier B., Begue D., et al. Medication errors in intravenous drug preparation and administration: a multicentre audit in UK, Germany and France. Qual Saf Health Care 2005, 14:190-195.
34. Guchelaar H.J., Colen H.B.B., Kalmeijer M.D., et al. Medication errors, hospital pharmacist perspective. Drugs 2005, 65:1735-1746.
35. Greengold N.L., Shane R., Schneider P., et al. The impact of dedicated medication nurses on the medication administration error rate. Arch Intern Med 2003, 163:2359-2367.
36. Calabrese A.D., Erstad B.L., Brand K., et al. Medication administration errors in adult patients in the ICU. Intensive Care Med 2001, 27:1592-1598.
37. Hartwig S.C., Denger S.D., Schneider P.J. Severity-indexed incident report-based medication error-reporting program. Am J Hosp Pharm 1991, 48:2611-2616.
38. Tissot E., Cornette C., Capellier G., et al. Assessment of medication errors: methodological details. Intensive Care Med 1999, 25:1478.
39. Wirtz V., Taxis K., Barber N. An observational study of intravenous medication errors in the United Kingdom and in Germany. Pharm World Sci 2003, 25:104-111.
40. Taxis K., Barber N. Causes of intravenous medication errors: an ethnographic study. Qual Saf Health Care 2003, 5:343-347.
41. Taxis K., Barber N. Incidence and severity of intravenous drug errors in a German hospital. Eur J Clin Pharmacol 2004, 59:815-817.
42. Taxis K., Barber N. Ethnographic study of incidence and severity of intravenous drug errors. Br Med J 2003, 326:684-687.
43. Dubois C., Dive A., Bourtembourg M., et al. Apport d'un pharmacien hospitalier dans une unité de soins intensifs. Expérience aux cliniques universitaires UCL de Mont-Godinne 2002, AG AFPHB.
44. Serurier C., Chenot E.D., Vigneron J., et al. Assessment of injectable drug's administration in two intensive care units and determination of potential physico-chemical incompatibilities. Eur J Hosp Pharm Sci 2006, 5:96-99.
45. Tissot E., Cornette C., Demoly P., et al. Medication errors at the administration stage in an intensive care unit. Intensive Care Med 1999, 25:353-359.
46. Gikic M, Di Paolo ER, Panatier A, et al. Evaluation of physicochemical incompatibilities during parenteral drug administration in a pediatric intensive care unit. Pharm World Sci 2000:88-91.
47. Benjamin B. Proceedings of a summit on preventing patient harm and death from i.v. medication errors. Am J Health Syst Pharm 2008;65:2367-79.
48. Sanborn M.D., Moody M.L., Harder K.A., Pepper G.A., Scanlon M., Vaida A.J., Zuggic M. Second consensus development conference on the safety of intravenous drug delivery systems-2008. Am J Health Syst Pharm 2009, 66:185-192.
49. Shane R. Current status of administration of medicines. Am J Health Syst Pharm 2009, 66(suppl. 3):S42-S48.
50. Miller W.A., Smith G.L., Latiolais C.J. A comparative evaluation of compounding costs and contamination rates of intravenous admixture systems. DICP 1971, 5:51-60.
51. Allinson R.R., Stach P.E., Sherrin T.S., Latiolais C.J. Compounding times and contamination rates for preparing IV admixtures in three types of plastic containers. Am J Hosp Pharm 1979, 36:513-517.
52. Brier K.L., Latiolais C.J., Schneider P.J. Effect of laminar flow and clean room dress on contamination rates of intravenous admixtures. Am J Hosp Pharm 1981, 38:1144-1147.
53. Cousins D.H. Centralised intravenous additives services. Implementation manual 1990, Baxter Healthcare Ltd.
54. Needle R., Sizer T. The CIVAs handbook 1998, Pharmaceutical Press, Cambridge, UK.
55. Hecq J.D., Vandenbroucke J., Lefebure M.A., et al. Centralised intravenous additive service (CIVA). Implementation manual for Belgian hospital pharmacist 1999, BVZA-ABPH.
56. Allwood M., Wright P. The cytotoxic handbook 2002, Ratclifffe Medical Press, Oxford, UK. 4th ed.
57. Bing C.M. Extended stability of parenteral drugs 2001, ASHP, Bethesda, MD.
58. Catania P.N. King guide to parenteral admixtures 2009, King Guide Publications, Napa, California.
59. Hecq J.D. Stabilité des médicaments injectables en perfusion. Édition 2009. 27 ans de recherche bibliographique. 2009, ABPH-BVZA, Brussels.
60. Morris N. Australian handbook injectable drugs 1997, SHPA. 2nd ed.
61. Trissel L.A. Handbook on injectable drugs 2009, ASHP, Bethesda, MD.
62. Vigneron J, Gindre I, Daouphars M, Demoré B, Monfort P, Georget S, et al. Stabilis 3; http://www.stabilis.org/.
63. Turner D. A comparison of intravenous antibiotic reconstitution methods. 6th Congress of the European association of hospital pharmacists. Amsterdam; 2001.
64. Parker S.E., Davey P.G. Pharmacoeconomics of intravenous drug administration. Pharmacoeconomics 1992, 1:103-115.
65. Plumridge R.J. Cost minimisation study using monovial and vials for the preparation of imipenem/cilastatine intravenous infusions. Clin Drug Invest 1997, 13(4):215-219.
66. Plumridge R.J., Maher M. Justification of a pharmacy intravenous admixture service in an Australian hospital. Am J Hosp Pharm 1993, 50:463-466.
67. Hecq JD. Reconstitution de médicaments injectables en pharmacie hospitalière par un procédé de congélation/décongélation par micro-ondes. Thèse de doctorat en sciences pharmaceutiques; 2006.
68. Schlesser V., Hecq J.D., Vanbeckbergen D., Jamart J., Galanti L. Effect of freezing, long-term storage and microwave thawing on the stability of cefepime in 5% dextrose infusion P.V.C. bags. Int J Pharm Compd 2002, 6:391-394.
69. Awang D.V.C., Graham K.C. Microwave thawing of frozen drug solutions. Am J Hosp Pharm 1987, 44:2256.
70. Hecq J.D., Boitquin L.P., Vanbeckbergen D.F., Jamart J., Galanti L.M. Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4°C. Ann Pharmacother 2005, 39:1244-1248.
71. Hecq J.D., Berlage V., Vanbeckbergen D., Jamart J., Galanti L. Effects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusion. Can J Hosp Pharm 2004, 5:276-282.
72. Rodenbach M.P., Hecq J.D., Vanbeckbergen D., Jamart J., Galanti L. Effect of freezing, long-term storage, and microwave thawing on the stability of vancomycine hydrochloride in 5% dextrose infusions. Eur J Hosp Pharm Sci 2005, 11:111-113.
73. Trissel L.A. The new national standard for sterile preparation. Hosp Pharm 2004, 39:900-904.
74. Fox B.I., Felkey B.G. Automated intravenous preparation: robots for the pharmacy. Hosp Pharm 2009, 44(3):255-257.
75. Allwood M.C. Assigning shelf-lives to CIVA service products. Br J Pharm Pract 1990, 12:270-272.
76. Hecq J.D. Ten years of European hospital pharmacy history centralized intravenous additives services. Eur J Hosp Pharm Sci 2004, 10:47.